References
- WHO. Mental Health: New Understanding, New Hope. France: WHO; 2001. Internet. Available from: http://www.who.int/whr/2001/en/index.html (accessed 1 Oct 2009).
- Shea MT, Elkin I, Imber SD, Sotsky SM, Watkins JT, Collins JF, . Course of depressive symptoms over follow-up. Findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry 1992;49:782–7.
- Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, . Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999;156:1000–6.
- Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, . Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol. 2008;22:343–96.
- Van Marwijk H, Grundmeijer H, Bijl D, Van Gelderen M, De Haan M, Van Weel-Baumgarten E, . NHG-standaard depressieve stoornis (depressie) (eerste herziening). Huisarts Wet. 2003;46:614–33.
- National Collaborating Centre for Mental Health. Depression: Management of depression in primary and secondary care. Rushden: The British Psychological Society and Gaskell; 2007. Internet. Available from: http://www.nice.org.uk/Guidance/CG23/Guidance/pdf/English (accessed 8 Feb 2008).
- Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, . Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review. Lancet 2003;361:653–61.
- Kaymaz N, van OJ, Loonen AJ, Nolen WA. Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 2008;69:1423–36.
- Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, . Use of mental health services in Europe: Results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;109:47–54.
- Vuorilehto MS, Melartin TK, Rytsala HJ, Isometsa ET. Do characteristics of patients with major depressive disorder differ between primary and psychiatric care? Psychol Med. 2007;37:893–904.
- Van Voorhees BW, Cooper LA, Rost KM, Nutting P, Rubenstein LV, Meredith L, . Primary care patients with depression are less accepting of treatment than those seen by mental health specialists. J Gen Intern Med. 2003;18:991–1000.
- Powers RH, Kniesner TJ, Croghan TW. Psychotherapy and pharmacotherapy in depression. J Ment Health Policy Econ. 2002;5:153–61.
- Hayes D. Recent developments in antidepressant therapy in special populations. Am J Manag Care 2004;10:S179–85.
- Moreno C, Arango C, Parellada M, Shaffer D, Bird H. Antidepressants in child and adolescent depression: where are the bugs? Acta Psychiatr Scand. 2007;115:184–95.
- Mueller TI, Kohn R, Leventhal N, Leon AC, Solomon D, Coryell W, . The course of depression in elderly patients. Am J Geriatr Psychiatry 2004;12:22–9.
- Deutsche Gesellschaft für Psychiatrie PuND. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression. Berlin: DGPPN; 2009. Internet. Available from: http://www.versorgungsleitlinien.de (accessed 5 Jan 2010).
- Heyrman J, Declercq T, Rogiers R, Pas L, Michels J, Goetinck M, . Depressie bij volwassenen: aanpak door de huisarts. Huisarts Nu. 2008;37:284–317.
- Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, . World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders in primary care. World J Biol Psychiatry 2007;8:67–104.
- Institute for Clinical Systems Improvement. ICSI Health Care guideline: Major depression in adults in primary care. Bloomington: ICSI; 2009. Internet. Available from: http://www.icsi.org/ (accessed 1 Oct 2009).
- Agence Française de Sécurité Sanitaire des Produits de Santé. Bon usage des medicaments antidepresseurs dans le traitement des troubles depressifs et des troubles anxieux de l'adulte. Saint Denis: AFSSAPS; 2006. Internet. Available from: http://www.afssaps.fr (accessed 15 Oct 2009).
- Helsedirektoratet. Nasjonale retningslinjer for diagnostisering og behandling av voksne med depresjon i primær- og spesialisthelsetjenesten. Oslo: Helsedirektoratet; 2009. Internet. Available from: http://www.helsedirektoratet.no (accessed 15 Dec 2009).
- Landelijke stuurgroep richtlijnontwikkeling in de GGZ. Multidisciplinaire richtlijn DepressieHouten: Trimbos-instituut; 2005. Internet. Available from: http://www.cbo.nl/ (accessed 30 May 2008).
- Camden and Islington Mental Health. Depression guideline. London: Camden & Islington; 2003. Internet. Available from: http://www.cimh.info/ (accessed 14 Mar 2008).
- New Zealand Guidelines Group. Identification of common mental disorders and management of depression in primary care. Ministry of Health; 2008. Internet. Available from: http://www.nzgg.org.nz/ (accessed 1 Oct 2009).
- Kennedy SH, Lam RW, Cohen NL, Ravindran AV. Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry 2001;46:38S–58S.
- Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, . Multiple recurrences of major depressive disorder. Am J Psychiatry 2000;157:229–33.
- Wilson I, Duszynski K, Mant A. A 5-year follow-up of general practice patients experiencing depression. Fam Pract. 2003;20:685–9.
- Wade A, Crawford GM, Angus M, Wilson R, Hamilton L. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. Int Clin Psychopharmacol. 2003;18:133–41.
- Akerblad AC, Bengtsson F, von KL, Ekselius L. Response, remission and relapse in relation to adherence in primary care treatment of depression: a 2-year outcome study. Int Clin Psychopharmacol. 2006;21:117–24.
- Akerblad AC, Bengtsson F, Ekselius L, von KL. Effects of an educational compliance enhancement programme and therapeutic drug monitoring on treatment adherence in depressed patients managed by general practitioners. Int Clin Psychopharmacol. 2003;18:347–54.
- Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med- 2009;6:e1000097. doi:10.1371/journal.pmed1000097.